• Sun. Apr 12th, 2026

FDA panel narrowly moves to authorize Merck’s COVID treatment pill – CNET

By

Dec 1, 2021

The FDA still needs to officially authorize molnupiravir for people at high risk of severe COVID-19.

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy